pricing

定价
  • 文章类型: Journal Article
    人工智能在营销中的使用不断升级,极大地影响了消费者生活的各个方面。这项研究,以归因理论和S-O-R理论为基础,采用基于场景的实验方法来模拟两种不同的购买环境。目的是调查消费者对人工智能发起的定价的心理和行为反应。通过SPSS方差分析和Bootstrap分析,测试了人工智能发起的定价对消费者行为的影响机制,揭示了心理感知和消费者感知伦理的中介变量,以及感知企业控制权的中介变量。从中国客户那里收集数据以检验本研究的模型。对841份有效问卷进行方差分析和SPSSBootstrap分析。结果表明:(1)与营销人员相比,消费者对AI发起的定价表现出更高的回购和口碑推荐行为以及更低的抱怨和转换行为;(2)AI发起的定价导致消费者的心理感知减少和道德感知增强。伦理观念是一个完整的中介,而心理感知的中介作用较小;(3)感知企业控制在人工智能发起的定价对消费者行为的影响中起调节作用。也就是说,当消费者知道企业可以控制定价代理时,人工智能发起的定价导致较低的回购和口碑推荐行为,以及比人类更高的抱怨和转换行为实例。
    The escalating use of artificial intelligence in marketing significantly impacts all aspects of consumer life. This research, grounded in attribution theory and S-O-R theory, employs scenario-based experimental methods to simulate two distinct purchasing contexts. The aim is to investigate consumers\' psychological and behavioral responses to AI-initiated pricing. Through SPSS analysis of variance and Bootstrap analysis, the mechanisms of influence of AI-initiated pricing on consumer behavior are tested, revealing the mediating variables of mind perception and consumer perceived ethicality, as well as the mediating variables of perceived enterprise control. Data were collected from Chinese customers to test the model of this study. A total of 841 valid questionnaires were analyzed using ANOVA and Bootstrap analysis with SPSS. The results show that: (1) Consumers exhibit higher repurchase and word-of-mouth recommendation behaviors and lower complaint and switching behaviors for AI-initiated pricing compared to marketers; (2) AI-initiated pricing leads to diminished mind perceptions and augmented ethical perceptions among consumers. Ethical perceptions serve as a complete mediator, while mind perceptions play a less significant mediating role; (3) Perceived enterprise control plays a moderating role in the impact of AI-initiated pricing on consumer behavior. That is, when consumers know that the enterprise can control pricing agents, AI-initiated pricing leads to lower repurchase and word-of-mouth recommendation behaviors, and higher instances of complaining and switching behaviors than humans.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    中国国家卫生服务项目标准(NHSIS)建立了相对价值体系,在定价中发挥着重要作用。然而,关于NHSIS估计相对价值的客观性,很少有经验评估。
    本文比较了NHSIS和美国医疗保险医师费用表(MPFS)中70例常见外科手术的医师工作相对价值单位(wRVU)估计值。我们将样本程序的wRVU与基准程序(腹股沟疝修补术)的比率定义为标准化的相对值单位(SRVU)。用于标准化两个时间表的数据。我们检查了不同专业和程序的SRVU的排名和量化差异,以及SRVU如何影响两个时间表之间的程序报销价格。
    MHSIS估计的SRVU和MPFS估计的SRVU之间没有系统差异,但是MPFS估计的SRVU的离差大于MHSIS估计的离差,差异随着手术风险和技术复杂性的增加而增加。在心胸手术中,SRVU的差异显着。此外,SRVU是基于MPFS还是MHSIS,它们与支付价格之间存在正相关关系。然而,就SRVU对支付定价的影响而言,NHSIS系统低于MPFS系统。
    中国在估算医疗服务的相对价值方面取得了进步,但估值方法存在缺陷及其对定价的影响。应将模块化评估方法视为优化改革的组成部分。
    UNASSIGNED: China\'s National Health Service Items Standard (NHSIS) establishes a relative value system and plays an important role in pricing. However, there are few empirical evaluations of the objectivity of the NHSIS-estimated relative value.
    UNASSIGNED: This paper presents a comparison between physician work relative value units (wRVUs) estimates for 70 common surgical procedures from NHSIS and those from the U.S. Medicare Physician Fee Schedule (MPFS). We defined the ratio of the wRVUs for sample procedures to the benchmark procedure (inguinal hernia repair) as a standardized relative value unit (SRVU), which was used to standardize the data for both schedules. We examined the variances in the ranking and quantification of SRVUs across specialties and procedures, as well as how SRVUs impact procedure reimbursement prices between the two schedules.
    UNASSIGNED: There was no systematic difference between MHSIS-estimated SRVUs and MPFS-estimated, but the dispersion of MPFS-estimated SRVU was greater than that of MHSIS-estimated, and the discrepancies increased with surgical risk and technical complexity. The discrepancies of SRVUs were significant in cardiothoracic procedures. Additionally, whether SRVUs were based on MPFS or MHSIS, there was a positive association between them and payment prices. However, in terms of the impact of SRVUs on payment pricing, the NHSIS system was lower than the MPFS system.
    UNASSIGNED: China has made incremental progress in estimating the relative value of healthcare services, but there are shortcomings in valuation methods and their impact on pricing. The modular assessment method should be considered as a component to optimize reform.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    随着电动汽车(EV)的快速发展,废旧动力电池的迅速增长需要开发高效的电池回收电子平台。这一领域的一个关键挑战是供需之间的不匹配。作为回应,提出了一个动态优化模型,以捕获非均衡的供需关系及其在连续时期内的联系,以实现对交易量变化的动态模拟和预测。同时,定价和佣金设定策略基于最大化社会福利和平台收入的目标进行优化。结果表明,由于回收量较低,提高回收价格通常会增加平台收入,加剧了环境成本,导致社会福利降低。此外,平台收入对佣金率比社会福利更敏感,更容易受到回收价格的影响。此外,与优先考虑收入相比,优先考虑社会福利会导致更高的回收量,但这也造成了供需之间的不平衡,破坏回收市场的稳定。通过动态定价和佣金策略,本研究丰富了动力电池第三方回收模式的文献,提供了一个更符合现实操作条件的新颖视角。我们的发现有助于平台澄清定价和佣金决策对平台收入和社会福利的影响,从而为其决策优化提供支持。
    With the rapid advancement of electric vehicles (EVs), the burgeoning increase in used power batteries necessitates the development of efficient battery recycling e-platforms. A key challenge in this field is the mismatch between supply and demand. In response, a dynamic optimization model is proposed to capture the non-equalizing supply-demand relationship and its linkage over continuous periods to enable dynamic simulations and predictions of transaction volume changes. Meanwhile, pricing and commission-setting strategies are optimized based on the objectives of maximizing social welfare and platform revenue. The result shows that due to the lower recycling volumes that result, increasing the recycling price usually increases platform revenues, exacerbates environmental costs, and leads to lower social welfare. Moreover, platform revenues are more sensitive to commission rates than social welfare, which is more vulnerable to recycling prices. Furthermore, prioritizing social welfare leads to a higher recycling volume compared to prioritizing revenue, but it also creates an imbalance between supply and demand, destabilizing the recycling market. With the dynamic pricing and commission strategies, this study enriches the literature in the third-party recycling mode for power batteries, offering a novel perspective that is more aligned with real-world operational conditions. Our findings help platforms clarify the impact of pricing and commission decisions on platform revenue and social welfare and thereby provide support for their decision optimization.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:适应症特定价值定价(ISVBP)是一种机制,通过使药品价格与价值一致,允许多适应症药物的价格在不同适应症之间变化。然而,ISVBP对不同适应症患者的总体影响尚不确定.本研究考察了ISVBP对多适应症药物的理论福利效应,并比较了ISVBP和单一定价下的消费者剩余,后者基于加权平均值。
    方法:我们考虑了一种医疗保健系统,该系统具有基于药物价值的政府谈判的药物价格。我们假设一种药物具有两个适应症和每个适应症的一个相关比较器。在基础病例中,药物的价值在每个适应症的患者中均匀分布。我们还考虑了具有指数和帕累托分布药物值的替代方案。进行了数值模拟,以探索与单一定价相比,ISVBP改善患者福利的潜在设置。
    结果:理论分析表明,从单一定价到ISVBP,消费者剩余变化严格为非正。因此,在感兴趣的环境中,这并不是改善患者的福利。数值模拟在各种价值分布情况下证实了这一结果。
    结论:本研究提供了ISVBP对多适应症药物患者福利影响的见解。我们没有确定ISVBP可以增强患者整体健康的条件,建议谨慎实施。未来的研究应该研究与创新激励相关的动态福利影响,因为它们可能会在未来显著影响人口健康。
    Indication-specific value-based pricing (ISVBP) is a mechanism that allows the prices of multi-indication drugs to vary across indications by aligning the drug prices with value. However, the overall impact of ISVBP on patients across indications is uncertain. This study examines the theoretical welfare effects of ISVBP for multi-indication drugs and compares consumer surplus under ISVBP and single pricing, the latter of which is based on the weighted average value.
    We considered a healthcare system with government-negotiated drug prices based on the value of drugs. We assumed a drug with 2 indications and 1 relevant comparator for each indication. The value of the drug was uniformly distributed among the patients of each indication in the base case. We also considered alternative scenarios with exponentially and Pareto distributed drug values. Numerical simulations were conducted to explore potential settings where ISVBP was welfare-improving for patients compared with single pricing.
    The theoretical analysis showed that the consumer surplus change was strictly non-positive from single pricing to ISVBP. Therefore, it was not welfare-improving for patients in the settings of interest. Numerical simulations confirmed this result across various scenarios of value distributions.
    This study provides insights into the patient welfare implications of ISVBP for multi-indication drugs. We did not identify conditions under which ISVBP can enhance overall patient well-being, suggesting that it should be implemented cautiously. Future research should examine dynamic welfare implications related to innovation incentives because they may significantly affect population health in the future.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:越来越多的商用深度学习计算机辅助检测(DL-CAD)系统可用,但其节省成本的潜力在很大程度上是未知的。本研究旨在深入了解DL-CAD在不同阅读模式下的适当定价,以节省成本,并确定潜在的最具成本效益的肺癌筛查阅读模式。
    方法:在三个代表性设置中,DL-CAD被评估为并发,预筛查,第二个读者。进行范围审查以估计有和没有DL-CAD的放射科医生阅读时间。在美国收集了放射科医生的每小时费用(196欧元),英国(127欧元),波兰(45欧元)并计算了节约时间的货币当量。对于DL-CAD,一次性投资51,616欧元,计算出达到收支平衡的筛查CT的最低数量。
    结果:每例无DL-CAD的平均读取时间为162(95%CI:111-212)秒,作为并发和预筛选读取器,DL-CAD减少了77(95%CI:47-107)和104(95%CI:71-136)秒,分别,DL-CAD作为第二读者增加了33-41秒。在美国,并发阅读的每例费用为1.0-4.3欧元,筛查前阅读的费用为0.8-5.7欧元,英国,和波兰。以一次性投资实现盈亏平衡,并行阅读器的CT扫描最少数量为12,300-53,600,以及9400-65,000个国家/地区的预筛选读者。
    结论:鉴于当前定价,DL-CAD必须在按病例付费的情况下定价低于6欧元,或在高工作量环境中使用,以在肺癌筛查中达到收支平衡。DL-CAD作为预筛选阅读器显示出最大的节省成本的潜力。
    深度学习计算机辅助肺结节检测(DL-CAD)软件必须在按案例付费的情况下定价低于6欧元,或者必须在高工作量环境中使用一次性投资,以实现收支平衡。DL-CAD作为预筛选阅读器具有最大的成本节约潜力。
    结论:•DL-CAD在按案例付费的情况下必须大大低于6欧元才能达到收支平衡。•必须在高工作量筛选环境中使用DL-CAD以实现收支平衡。•DL-CAD作为预筛选阅读器显示出最大的节省成本的潜力。
    OBJECTIVE: An increasing number of commercial deep learning computer-aided detection (DL-CAD) systems are available but their cost-saving potential is largely unknown. This study aimed to gain insight into appropriate pricing for DL-CAD in different reading modes to be cost-saving and to determine the potentially most cost-effective reading mode for lung cancer screening.
    METHODS: In three representative settings, DL-CAD was evaluated as a concurrent, pre-screening, and second reader. Scoping review was performed to estimate radiologist reading time with and without DL-CAD. Hourly cost of radiologist time was collected for the USA (€196), UK (€127), and Poland (€45), and monetary equivalence of saved time was calculated. The minimum number of screening CTs to reach break-even was calculated for one-time investment of €51,616 for DL-CAD.
    RESULTS: Mean reading time was 162 (95% CI: 111-212) seconds per case without DL-CAD, which decreased by 77 (95% CI: 47-107) and 104 (95% CI: 71-136) seconds for DL-CAD as concurrent and pre-screening reader, respectively, and increased by 33-41 s for DL-CAD as second reader. This translates into €1.0-4.3 per-case cost for concurrent reading and €0.8-5.7 for pre-screening reading in the USA, UK, and Poland. To achieve break-even with a one-time investment, the minimum number of CT scans was 12,300-53,600 for concurrent reader, and 9400-65,000 for pre-screening reader in the three countries.
    CONCLUSIONS: Given current pricing, DL-CAD must be priced substantially below €6 in a pay-per-case setting or used in a high-workload environment to reach break-even in lung cancer screening. DL-CAD as pre-screening reader shows the largest potential to be cost-saving.
    UNASSIGNED: Deep-learning computer-aided lung nodule detection (DL-CAD) software must be priced substantially below 6 euro in a pay-per-case setting or must be used in high-workload environments with one-time investment in order to achieve break-even. DL-CAD as a pre-screening reader has the greatest cost savings potential.
    CONCLUSIONS: • DL-CAD must be substantially below €6 in a pay-per-case setting to reach break-even. • DL-CAD must be used in a high-workload screening environment to achieve break-even. • DL-CAD as a pre-screening reader shows the largest potential to be cost-saving.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:近年来推行了多项旨在改善中国人口健康的改革,包括几个旨在改善创新药物的获取。我们试图回顾影响中国创新药物获取的当前因素,并预测未来趋势。
    方法:有针对性地回顾已发表的有关中国医疗保健系统的文献和统计数据,进行了医疗保险和报销流程,以及对参与创新药报销的五名中国专家的采访。
    结果:由于取消了省级途径,中国的药品报销越来越集中,国家医疗保障局的成立和国家报销药品目录(NRDL)的实施,现在是中国药品报销的主要途径。还有越来越多的其他渠道,患者可以通过这些渠道获得创新的治疗,包括各类商业保险和特殊准入。卫生技术评估(HTA)和卫生经济证据正在成为NRDL决策过程的关键要素。除了优化HTA决策,预计未来将越来越多地利用创新的风险分担协议,以优化对高度专业化技术的获取,并鼓励创新,同时保护有限的医疗保健基金。
    结论:中国的药品公共报销继续与欧洲在HTA方面广泛使用的方法更加紧密地保持一致,卫生经济学和定价。创新药公共报销的决策过程的集中化使得评估和获取的一致性,这优化了中国人口健康的改善。
    OBJECTIVE: Multiple reforms aimed at improving the Chinese population\'s health have been introduced in recent years, including several designed to improve access to innovative drugs. We sought to review current factors affecting access to innovative drugs in China and to anticipate future trends.
    METHODS: Targeted reviews of published literature and statistics on the Chinese healthcare system, medical insurance and reimbursement processes were conducted, as well as interviews with five Chinese experts involved in the reimbursement of innovative drugs.
    RESULTS: Drug reimbursement in China is becoming increasingly centralized due to the removal of provincial pathways, the establishment of the National Healthcare Security Administration and the implementation of the National Reimbursement Drug List (NRDL), which is now the main route for drug reimbursement in China. There is also an increasing number of other channels via which patients may access innovative treatments, including various types of commercial insurance and special access. Health technology assessment (HTA) and health economic evidence are becoming pivotal elements of the NRDL decision-making process. Alongside the optimization of HTA decision making, innovative risk-sharing agreements are anticipated to be increasingly leveraged in the future to optimize access to highly specialized technologies and encourage innovation while safeguarding limited healthcare funds.
    CONCLUSIONS: Drug public reimbursement in China continues to align more closely with approaches widely used in Europe in terms of HTA, health economics and pricing. Centralization of decision-making processes for public reimbursement of innovative drugs allows consistency in assessment and access, which optimizes the improvement of the Chinese population\'s health.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    受到近年来流行的在线商业实践的启发,我们的目标是调查与传统的预售相比,涉及到的一个问题,这在本文中被称为“反向预售”(RAS)。我们考虑了市场中的竞争和信息不对称,并讨论了它们如何影响反向预售决策。我们提出了两个模型来评估RAS的收益,并描述在竞争中优化零售商定价和订购策略的条件。此外,我们研究了市场份额等因素的影响,在线评论,和等待时间,并为零售商做出决策提供见解。结果表明,当零售商或客户面临不确定性时,采用RAS具有优势,并且有利于更新评论信息。本文还发现,市场份额对零售商的利润和订货量都有正向影响,而在线评论对其折扣和订购决策有相反的影响。研究结果可以指导零售商制定灵活的订货计划,更好地迎合市场需求。
    Enlightened by popular online business practices emerging in recent years, we aim to investigate a problem involving a flipped procedure in contrast with traditional advance selling, which is referred to as \"reverse advance selling\" (RAS) in this paper. We consider competition and information asymmetry in the market and discuss how they affect the decisions in reverse advance selling. We propose two models to evaluate the benefits of RAS and to characterize the conditions that optimize the pricing and ordering policies for retailers under competition. Furthermore, we examine the impact of factors such as market share, online review, and waiting time and provide insights for retailers to make decisions. The results demonstrate the advantage of adopting RAS when retailers or customers face uncertainty and it is beneficial to update review information. This paper also finds that market share positively affects the profit as well as the ordering quantities of the retailer, while online reviews have opposite impacts on its discount and ordering decisions. The results can guide retailers to make flexible ordering plans that better cater to market demand.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    考虑到非正规回收企业在废旧产品回收市场的竞争,本文分析了制造商的以旧换新策略,并通过比较回收市场份额的变化来讨论实施以旧换新对回收市场竞争的影响,回收价格,和以旧换新计划实施前后的利润。没有以旧换新计划,制造商在回收市场上与非正规回收企业的竞争中始终处于劣势。随着以旧换新计划的实施,制造商提供的回收价格和制造商回收市场的份额不仅随着加工单位旧产品的收益而增加,而且随着新产品销售和旧产品回收的总利润率的增加。推行以旧换新计划,可以增强制造商在与非正规回收企业竞争中的竞争力,导致制造商在回收市场上获得更多的份额和利润,促进制造商在新产品销售和旧产品回收利用方面的健康可持续发展。
    Considering the competition of informal recycling enterprises in the waste and old product recycling market, this paper analyzes the trade-in strategy of manufacturers and discusses the effect of implementing trade-in on the competition in the recycling market by comparing changes in recycling market shares, recycling prices, and profits before and after the implementation of a trade-in program. Without a trade-in program, manufacturers are always in an inferior position in the competition with informal recycling enterprises in the recycling market. With the implementation of a trade-in program, the recycling prices provided by manufacturers and shares of recycling market of manufacturers not only increase with the earnings of processing a unit old product, but also increase with the total profit margin of sales of new products and recycling of old products. The implementation of a trade-in program can enhance the competitiveness of manufacturers in their competition with informal recycling enterprises, causing manufacturers to obtain more shares and profits in the recycling market, and promoting the healthy and sustainable development of manufacturers in the sale of new products and the recycling of old products.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    环境污染责任保险对于中国实现减排目标的重要性日益凸显。保险定价是制约环境污染责任保险市场份额的关键因素,从布莱克-斯科尔斯定价模型的角度来看,这反过来又影响了中国保险公司的偿付能力。首先,本文分析了我国环境污染强制责任保险存在的问题。本文运用Black-Scholes定价模型对强制环境污染责任保险的价格进行了分析,并获得2.44%的高保费保险费率。此外,它使用资产和负债数据进行多元回归分析,取自年度报告,确定影响偿付能力充足率的三个关键因素,即,资本债务比率,反映公司资产结构;资产净利率,反映具有实际偿债能力的资产规模;和索赔比率,反映企业质量。根据对中国保险条款(CIC)公司的回归分析和稳健性检验结果,中国人民保险公司(PICC),和亚太财产和意外伤害保险(API)公司,结果表明,总资产的影响,总债务,资本债务比率,索赔比率,资产净利率对偿付能力充足率的影响显著,关于系数的大小。根据上一个责任保险周期中发现的Black-Scholes定价模型,并针对环境污染责任保险支出存在的问题,本文提出了有利于提高我国保险公司偿付能力的建议。
    Environmental pollution liability insurance is becoming increasingly important for China to achieve its emission reduction targets. Insurance pricing is a crucial factor restricting the market share of environment pollution liability insurance, from the perspective of the Black-Scholes pricing model, which in turn has influenced the solvency of insurance companies in China. Firstly, this study analyzes the problems existing in compulsory liability insurance for environmental pollution in China. It proceeds with analyzing the price of compulsory environmental pollution liability insurance using the Black-Scholes pricing model, and derives a high premium insurance rate of 2.44%. Moreover, it performs a multivariate regression analysis using the asset and liability data, taken from the annual report, to identify three key factors affecting the solvency adequacy ratio, namely, capital debt ratio, reflecting the company asset structure; net interest rate on assets, reflecting the asset scale with actual solvency; and claim ratio, reflecting the business quality. Based on the results of regression analysis and robustness test for the China Insurance Clauses (CIC) company, People\'s Insurance Company of China (PICC), and Asia-Pacific Property & Casualty Insurance (API) company, it is shown that the effect of total asset, total debt, capital debt ratio, claim ratio, and net interest rate on assets on the solvency adequacy ratio is significant, with respect to the size of the coefficients. Based on the Black-Scholes pricing model found in the previous cycle of liability insurance, and keeping in view the existing problems of environmental pollution liability insurance expenditure, this paper presents suggestions that are conducive to improving the solvency of insurance companies in China.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    全渠道销售在冠状病毒大流行中激增。本文建立了一个分析模型,以研究企业何时可以从实施在线购买和店内提货(BOPS)的全渠道战略中受益。其中市场特征是通过产品估值和在线等待成本的二维异质性来捕获的。商店访问成本的增加将降低BOPS消费者的支付意愿,但它也将加强BOPS对传统双渠道的侵蚀。结果表明,当商店访问成本相对较高时,公司可以从BOPS策略中受益。这很好地解释了BOPS全渠道的快速发展,因为在COVID-19期间,商店参观成本很高。此外,与传统的双渠道销售形成鲜明对比的是,在传统的双渠道销售中,较高的门店拜访成本总是会伤害公司,BOPS下的利润在商店访问成本中可能是非单调的,公司可以从更高的商店访问成本中受益。具体来说,交叉销售效应的结合,BOPS侵占效应和BOPS扩张减少效应与门店参观成本相关,可导致U形或倒U形BOPS利润。此外,引入BOPS激励公司提高或降低最优价格,以商店访问成本为条件。对于消费者来说,线上和线下消费者也可以间接受益于BOPS战略,虽然他们可能不会享受BOPS服务。
    Omnichannel sales surge in the coronavirus pandemic. This paper establishes an analytical model to study when a firm can benefit from implementing the omnichannel strategy of buy-online and pick-up in-store (BOPS), where the market characteristics are captured by the two-dimensional heterogeneity of product valuation and online waiting cost. The increase in the store visiting cost will reduce BOPS consumers\' willingness to pay, but it will also strengthen the encroachment of BOPS on traditional dual-channel. The results show that the firm can benefit from the BOPS strategy when the store visiting cost is relatively high. This well explains the rapid development of the omnichannel with BOPS because of a high store visiting cost during COVID-19. Furthermore, sharply contrasting to the traditional dual-channel sales in which a higher store visiting cost always hurts the firm, the profit under BOPS can be nonmonotonic in the store visiting cost and the firm can benefit from a higher store visiting cost. Specifically, the combination of cross-selling effect, BOPS encroachment effect and BOPS expansion reduction effect associated with the store visiting cost can result in a U-shaped or inverse U-shaped BOPS profit. In addition, introducing BOPS motivates the firm to either increase or decrease the optimal price, conditional on the store visiting cost. For consumers, online and offline consumers can also indirectly benefit from the BOPS strategy, though they may not enjoy the BOPS service.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号